Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity

Mengrui Liu(Columbia University Irving Medical Center), Shiqi Hu(Columbia University Irving Medical Center), Na Yan(Columbia University Irving Medical Center), Kristen D. Popowski(University of North Carolina at Chapel Hill), Ke Cheng(University of North Carolina at Chapel Hill)
Nature Nanotechnology
January 11, 2024
10.1038/s41565-023-01580-3
Cited by 233Open Access
Full Text

Abstract

Related Papers

Interleukin-12 and the regulation of innate resistance and adaptive immunity
Giorgio Trinchieri|Nature reviews. Immunology|2003|3.9k
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
John P. Leonard, Matthew L. Sherman, Gerald L. Fisher et al.|PubMed|1997|814
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson, Ingunn M. Stromnes, Philip D. Greenberg|Cancer Cell|2017|701
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall, Ayush Verma, Gillis R. Otten et al.|Proceedings of the National Academy of Sciences|2012|658
Interleukin-12: Biological Properties and Clinical Application
Michele Del Vecchio, Emilio Bajetta, Stefania Canova et al.|Clinical Cancer Research|2007|600